William Geist Power - 01 Feb 2022 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role: President, Protein Sciences
Signature: /s/ Brenda S. Furlow as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed.
Issuer symbol: TECH
Transactions as of: 01 Feb 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 29 Sep 2022, 16:10:46 UTC
Date Of Original Report: 03 Feb 2022
Previous filing: 03 Feb 2022
Next filing: 17 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TECH	Restricted Stock Units	Award	$0	+2,490		$0.000000	2,490	01 Feb 2022	Common Stock	2,490		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed solely to move this grant of restricted stock units from Table I (where it was originally reported) to Table II.
F2	Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3	Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025.